Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: valganciclovirFind trials that include: Any drugs shown Results 1-4 of 4 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment Status: ActivePhase: Phase IIIType: Supportive care, TreatmentAge: 12 and overTrial IDs: SHP620-303, NCI-2016-01720, 2015-004725-13, NCT02931539 2. Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients Status: ActivePhase: Phase IIIType: Supportive care, TreatmentAge: 16 and overTrial IDs: SHP620-302, NCI-2017-00422, 2015-004726-34, NCT02927067 3. Tocilizumab with or without Zidovudine and Valganciclovir in Treating Patients with Kaposi Sarcoma Herpes Virus-Associated Multicentric Castleman Disease Status: ActivePhase: Phase IIType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: 11-C-0233, NCI-2013-01504, 110233, P10788, NCT01441063 4. Natural History of Zidovudine and Valganciclovir or Rituximab and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients with Kaposi Sarcoma-Associated Herpes Virus Status: ActivePhase: No phase specifiedType: Biomarker/Laboratory analysis, Natural history/Epidemiology, TreatmentAge: 18 and overTrial IDs: 11-C-0220, NCI-2013-01499, 110220, P10760, NCT01419561 Select All on Page Start Over
